Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease

被引:0
|
作者
Fiorino, G. [1 ]
Ruiz-Aguello, M. B. [2 ]
Maguregui, A. [2 ]
Nagore, D. [2 ]
Radice, S. [1 ]
Gilardi, D. [1 ]
Correale, C. [1 ]
Allocca, M. [1 ]
Furfaro, F. [1 ]
Alfieri, M. [1 ]
Martinez, A. [2 ]
Danese, S. [1 ,3 ]
机构
[1] Humanitas Clin & Res Ctr, Dept Gastroenterol, Milan, Italy
[2] Progenika Biopharma SA, R&D Dept, Derio, Spain
[3] Humanitas Univ, Dept Biomed Sci, Milan, Italy
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P633
引用
收藏
页码:S403 / S404
页数:2
相关论文
共 50 条
  • [1] ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE
    Fiorino, Gionata
    Ruiz-Arguello, Begona
    Maguregui, Ainara
    Nagore, Daniel
    Radice, Simona
    Gilardi, Daniela
    Correale, Carmen
    Allocca, Mariangela
    Furfaro, Federica
    Alfieri, Marina F.
    Maritnez, Antonio
    Danese, Silvio
    GASTROENTEROLOGY, 2017, 152 (05) : S386 - S386
  • [2] ANTIBODIES TO INFLIXIMAB IN REMICADE-TREATED RHEUMATIC PATIENTS SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILAR CT-P13
    Ruiz-Arguello, B.
    Maguregui, A.
    del Agua, A. Ruiz
    Pascual-Salcedo, D.
    Martinez, A.
    Jurado, T.
    Plasencia, C.
    Balsa, A.
    Rosas, J.
    Llinares-Tello, F.
    Torres, N.
    Martinez, A.
    Nagore, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 58 - 58
  • [3] Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease
    Fiorino, Gionata
    Begona Ruiz-Arguello, M.
    Maguregui, Ainara
    Nagore, Daniel
    Correale, Carmen
    Radice, Simona
    Gilardi, Daniela
    Allocca, Mariangela
    Furfaro, Federica
    Martinez, Antonio
    Danese, Silvio
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (03) : 601 - 606
  • [4] Full Interchangeability in Regards to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease
    Katsanos, Konstantinos H.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    Christodoulou, Dimitrios K.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (03) : 465 - 466
  • [5] Infliximab biosimilar CT-P13 for inflammatory bowel disease
    Bonovas, Stefanos
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (06): : 373 - 375
  • [6] Safety and efficacy of switching from infliximab biosimilar CT-P13 to infliximab biosimilar SB2 in patients with inflammatory bowel disease
    Lovero, Rosa
    Losurdo, Giuseppe
    La Fortezza, Rosa Federica
    Terracciano, Fulvia
    Biscaglia, Giuseppe
    Martino, Giuseppina
    Nardella, Marianna
    Di Leo, Alfredo
    Principi, Mariabeatrice
    Andriulli, Angelo
    Bossa, Fabrizio
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (02) : 201 - 207
  • [7] SAFETY AND EFFICACY OF INFLIXIMAB BIOSIMILAR SB2 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE WHO UNDERWENT A SWITCH FROM INFLIXIMAB BIOSIMILAR CT-P13
    Lovero, R.
    Losurdo, G.
    Biscaglia, G.
    Valvano, M. R.
    Biancofiore, A.
    Martino, G.
    Nardella, M.
    Andriulli, A.
    Principi, M.
    Bossa, F.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E227 - E227
  • [8] CT-P13: a review on a biosimilar to infliximab in the treatment of inflammatory bowel disease
    Albshesh, Ahmad
    Ben-Horin, Shomron
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (10) : 971 - 978
  • [9] A review on biosimilar infliximab, CT-P13, in the treatment of inflammatory bowel disease
    Farkas, Klaudia
    Molnar, Tamas
    IMMUNOTHERAPY, 2018, 10 (02) : 107 - 117
  • [10] RAPID DETECTION OF ANTI-INFLIXIMAB ANTIBODIES IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13: PERFORMANCE COMPARISON WITH ELISA
    Fiorino, Gionata
    Ametzazurra, Amagoia
    Nagore, Daniel
    Hernandez, Alba Maria
    Torres, Nerea
    Radice, Simona
    Gilardi, Daniela
    Correale, Carmen
    Allocca, Mariangela
    Furfaro, Federica
    Alfieri, Marina F.
    Pascual, Javier
    Recalde, Xabier
    Martinez, Antonio
    Danese, Silvio
    GASTROENTEROLOGY, 2017, 152 (05) : S384 - S384